Traws Pharma, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Symbol
TRAW on Nasdaq
Location
Newtown, PA
Fiscal year end
31 December
Latest financial report
13 Nov 2025

Quick Takeaways

  • TRAW - Traws Pharma, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric: Return On Equity -1060%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+680%</span>.
  • Most recent SEC facts end date: 10 Nov 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-11-10) highlights Return On Equity -1059.6%, Return On Assets -124.5%, and Current Ratio 1.22x.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

46.8/100

Caution Confidence low

Return On Equity

-1060%

Metric score 0.0/100

Return On Assets

-125%

Metric score 0.0/100

Financial Health

Current Ratio
1.22x

Strengths

Current Ratio and NetIncomeLoss YoY

Watchpoints

Return On Equity and Return On Assets

Key metrics snapshot

Return On Equity

-1060%

YoY: +680%

Industry median: -43% (n=675)

View history

Return On Assets

-125%

YoY: +164%

Industry median: -47% (n=673)

View history

Current Ratio

1.22x

YoY: +14%

Industry median: 3.39x (n=667)

View history

NetIncomeLoss YoY

53%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -1060% +680%
Return On Assets -125% +164%

Financial Health

Metric Latest value YoY change
Current Ratio 1.22x +14%

Growth

Metric Latest value YoY change
NetIncomeLoss YoY 53%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 7,990,867 +164%
Common Stock, Shares, Outstanding 7,131,151 +136%
Common Stock, Value, Issued $71,000 +137%
Weighted Average Number of Shares Outstanding, Basic 8,818,859 +817%
Weighted Average Number of Shares Outstanding, Diluted 8,818,859 +817%

Additional Metrics

Metric Latest value YoY change
General and Administrative Expense $9,665,000 -11%
Operating Income (Loss) $15,785,000 +89%
Earnings Per Share, Basic -5 +87%
Earnings Per Share, Diluted -5 +87%
Other Assets, Current $92,000 -73%
Assets, Current $9,625,000 +7.9%
Property, Plant and Equipment, Net $7,000 -42%
Other Assets, Noncurrent $240,000 +23900%
Assets $12,443,000 +39%
Accounts Payable, Current $5,105,000 -6.7%
Employee-related Liabilities, Current $774,000 +34%
Accrued Liabilities, Current $2,782,000 +5%
Liabilities, Current $7,887,000 -5.5%
Liabilities $7,898,000 -28%
Accumulated Other Comprehensive Income (Loss), Net of Tax $6,000
Retained Earnings (Accumulated Deficit) $632,541,000 -2.1%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $4,545,000
Liabilities and Equity $12,443,000 +39%
Common Stock, Shares Authorized 250,000,000 0%
Common Stock, Shares, Issued 7,131,151 +136%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,420,000 +19%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $13,270,000 +53%
Preferred Stock, Shares Issued 7,440 0%
Preferred Stock, Shares Authorized 5,000,000 0%
Preferred Stock, Shares Outstanding 6,737 -9.4%
Amortization of Intangible Assets $14,000
Share-based Payment Arrangement, Expense $735,000 -47%
Preferred Stock, Par or Stated Value Per Share 0.01 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY